First Tracks Biotherapeutics, Inc. · NASDAQ:TRAX
Sirenia Capital Management LP reported a 7.20% stake in First Tracks Biotherapeutics, Inc. (Schedule 13G)
Event Jun 30, 2026 · Filed Aug 14, 2026
Sirenia Capital Management LP reported a 7.20% stake in First Tracks Biotherapeutics, Inc., 2,495,777 shares, as a passive investor on Jun 30, 2026. Filed Aug 14, 2026 (Schedule 13G).
- Stake
- 7.20%
- Shares
- 2,495,777
- Intent
- Passive
- What changed
- Crossed above 5%
- Filed together
- 2 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Sirenia Capital Management LP | 7.20% | 2,495,777 |
| Alex Silverstein | 7.20% | 2,495,777 |
Source
Related
- First Tracks Biotherapeutics, Inc.
- Sirenia Capital Management LP
- First Tracks Biotherapeutics, Inc. shareholders
- Form 4 · Orwin John A · Sep 17, 2026
- Form 4 · Ware J. Anthony · Sep 4, 2026
- Schedule 13G · TCG Crossover GP II, LLC · Aug 14, 2026
- Schedule 13G · Affinity Asset Advisors, LLC · Aug 13, 2026
- Schedule 13G · FMR LLC · Aug 6, 2026